Varenicline Tablet, Film Coated
Product Images NDC 50090-6447

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 50090-6447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
Bar chart titled 'Continuous Abstinence, Weeks 9 through 12,' comparing percentages for Varenicline 0.5 mg, Varenicline 1.0 mg BID, placebo, Varenicline Flexible, Bupropion SR 150 mg BID, and placebo across multiple studies (Study 2 to Study 5). The y-axis represents percentage from 0% to 60%, showing outcome variations among treatments.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A bar chart titled 'Continuous Abstinence, Weeks 9 through 52' comparing the effectiveness of various treatments including Varenicline 0.5 mg Bid, Varenicline 1.0 mg Bid, Varenicline Flexible, Bupropion SR 150 mg Bid, and placebo across multiple studies. The chart shows percentage abstinence on the vertical axis with error bars indicating variability for each treatment group.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph comparing the percentage of continuous abstinent participants over time in weeks during nontreatment follow-up for Varenicline 1.0 mg twice daily versus placebo. The x-axis shows weeks of follow-up, and the y-axis shows percentage abstinent, illustrating higher abstinence rates with Varenicline across the observed period.*
FDA Label Image

Label Image (Lbl500906447)

Label Image (Lbl500906447)
VARENICLINE 0.5 mg film-coated tablets in a bottle label by A-S Medication Solutions. The label specifies each tablet contains 0.5 mg of varenicline tartrate equivalent and indicates storage at 68 to 77 degrees Fahrenheit. The package contains 56 tablets with a note to see the package insert for dosage.*
FDA Label Image

Structure-1 (Structure 1)

Structure-1 (Structure 1)
Chemical structure diagram showing two molecular structures. The first is a generic molecular backbone with labeled groups including OH, COOH, COO- and R substituents. The second is a complex bicyclic compound with nitrogen atoms indicated, consistent with a heterocyclic amine structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.